We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
(+4.7%)
Cap. Flow
+$861M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$43.1M |
| 2 |
ExxonMobil
XOM
|
+$33.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$27.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$86.8M |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$42.6M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$30.6M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$22.1M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.29% |
| 2 | Financials | 14.18% |
| 3 | Technology | 13.8% |
| 4 | Industrials | 10.4% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
First Bancorp
FNLC
$396M
| $276K | ﹤0.01% |
12,823
-3,930
| -23% | -$78.6K |
|
2577
Rigel Pharmaceuticals
RIGL
$681M
| $276K | ﹤0.01% |
12,396
+1,763
| +17% | +$43.8K |
|
|
SIOX
2578
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $276K | ﹤0.01% |
2,684
+1,025
| +62% | +$102K |
|
|
B
2579
Barrick Mining
B
$61.5B
| $275K | ﹤0.01% |
12,860
| – | – |
|
2580
Ducommun
DCO
$2.7B
| $273K | ﹤0.01% |
13,799
-4,366
| -24% | -$74.4K |
|
2581
Graham Corp
GHM
$1.12B
| $273K | ﹤0.01% |
14,821
-614
| -4% | -$11.3K |
|
|
SNOW
2582
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $273K | ﹤0.01% |
21,019
-9,455
| -31% | -$94.7K |
|
|
SPNS
2583
DELISTED
Sapiens International
SPNS
| $272K | ﹤0.01% |
23,260
-2,107
| -8% | -$25.3K |
|
|
STRP
2584
DELISTED
Straight Path Communications Inc.
STRP
| $272K | ﹤0.01% |
9,825
+290
| +3% | +$9.59K |
|
|
LOXO
2585
DELISTED
Loxo Oncology, Inc
LOXO
| $271K | ﹤0.01% |
11,699
-958
| -8% | -$23.9K |
|
2586
Energy Recovery
ERII
$446M
| $270K | ﹤0.01% |
+30,381
| New | +$324K |
|
|
FSB
2587
DELISTED
Franklin Financial Network, Inc.
FSB
| $270K | ﹤0.01% |
+8,606
| New | +$258K |
|
|
MRLN
2588
DELISTED
Marlin Business Services Corp
MRLN
| $269K | ﹤0.01% |
16,477
+225
| +1% | +$3.35K |
|
|
ZIXI
2589
DELISTED
Zix Corporation
ZIXI
| $269K | ﹤0.01% |
71,774
+11,018
| +18% | +$43K |
|
|
IMMU
2590
DELISTED
Immunomedics Inc
IMMU
| $269K | ﹤0.01% |
115,948
+13,313
| +13% | +$44.5K |
|
|
ASCMA
2591
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $269K | ﹤0.01% |
17,462
-4,986
| -22% | -$81.1K |
|
2592
Enova International
ENVA
$6.33B
| $268K | ﹤0.01% |
36,430
+2,774
| +8% | +$19.6K |
|
2593
Teladoc Health
TDOC
$1.22B
| $268K | ﹤0.01% |
+16,730
| New | +$195K |
|
|
ADMS
2594
DELISTED
Adamas Pharmaceuticals
ADMS
| $268K | ﹤0.01% |
17,693
-394
| -2% | -$6.5K |
|
2595
Bassett Furniture
BSET
$164M
| $267K | ﹤0.01% |
11,161
-2,001
| -15% | -$58K |
|
2596
Ambev
ABEV
$48.1B
| $266K | ﹤0.01% |
45,020
| – | – |
|
2597
Triumph Financial Inc
TFIN
$1.81B
| $266K | ﹤0.01% |
16,606
-4,017
| -19% | -$63.8K |
|
|
TRVN
2598
DELISTED
Trevena, Inc.
TRVN
| $264K | ﹤0.01% |
67
+17
| +34% | +$79.8K |
|
2599
Central Garden & Pet Co
CENT
$2.69B
| $263K | ﹤0.01% |
+14,408
| New | +$211K |
|
2600
Ericsson
ERIC
$32.2B
| $263K | ﹤0.01% |
34,279
+289
| +0.9% | +$2.37K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2016 Portfolio in Review
As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
- RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
- RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
- RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
- RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.
Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.